Elsevier

Neurobiology of Disease

Volume 37, Issue 1, January 2010, Pages 130-140
Neurobiology of Disease

Interactions of peptide amidation and copper: Novel biomarkers and mechanisms of neural dysfunction

https://doi.org/10.1016/j.nbd.2009.09.016Get rights and content

Abstract

Mammalian genomes encode only a small number of cuproenzymes. The many genes involved in coordinating copper uptake, distribution, storage and efflux make gene/nutrient interactions especially important for these cuproenzymes. Copper deficiency and copper excess both disrupt neural function. Using mice heterozygous for peptidylglycine α-amidating monooxygenase (PAM), a cuproenzyme essential for the synthesis of many neuropeptides, we identified alterations in anxiety-like behavior, thermoregulation and seizure sensitivity. Dietary copper supplementation reversed a subset of these deficits. Wildtype mice maintained on a marginally copper-deficient diet exhibited some of the same deficits observed in PAM+/− mice and displayed alterations in PAM metabolism. Altered copper homeostasis in PAM+/− mice suggested a role for PAM in the cell type specific regulation of copper metabolism. Physiological functions sensitive to genetic limitations of PAM that are reversed by supplemental copper and mimicked by copper deficiency may serve as indicators of marginal copper deficiency.

Introduction

In both Menkes disease, with low levels of copper, and Wilson's disease, with elevated levels of copper, neural function is impaired (Madsen and Gitlin, 2007, Schlief and Gitlin, 2006, Cunliffe et al., 2001, Tumer and Horn, 1997). These diseases are rare, caused by mutations in ATP7A and ATP7B, respectively. In addition to these two copper transporting P type ATPases, the uptake and tissue-specific distribution of dietary copper involves additional transporters and copper-binding chaperones (Madsen and Gitlin, 2007, Schlief and Gitlin, 2006). Menkes patients and mottled/brindled (ATP7aMo-br) mice, an animal model for Menkes Disease, exhibit increased susceptibility to seizures and neurodegeneration which can be partially reversed with copper supplementation (Sheela et al., 2005). Similar symptoms result from dietary copper deficiency; livestock consuming a copper-deficient diet develop progressive ataxic myelopathy (Madsen and Gitlin, 2007, Kumar, 2006). In humans, acquired copper deficiency can accompany long-term parenteral nutrition or malabsorption; in addition to hematological symptoms, sensory ataxia and spastic gait may occur (Madsen and Gitlin, 2007). Biomarkers that accurately reflect mild changes in copper status have not yet been established (Harvey and McArdle, 2008).

Copper-dependent enzymes, which evolved with the appearance of atmospheric molecular oxygen, are rare, with about a dozen in mammals (Critchton and Pierre, 2001, Ridge et al., 2008). Peptidylglycine α-hydroxylating monooxygenase (PHM) and dopamine β-monooxygenase (DBM) are homologous copper-dependent monooxygenases, essential for the synthesis of α-amidated peptides and norepinephrine/epinephrine, respectively. The biosynthesis of amidated peptides, conserved from Planaria to humans, is compromised in mottled/brindled mice (Asada et al., 2005, Prigge et al., 2000, Steveson et al., 2003, Niciu et al., 2007). ATP7A must interact with Atox1, a cytoplasmic copper chaperone, to transport Cu(I) from the cytoplasm into the secretory pathway (Madsen and Gitlin, 2007, Prohaska and Gybina, 2004, Puig and Thiele, 2002).

Mutations of either PAM or ATP7A affect the vascular system and thermoregulation (Niciu et al., 2006, Niciu et al., 2007, Bousquet-Moore et al., 2009, Czyzyk et al., 2005, Al-Bitar et al., 2005, Ozawa et al., 2002, Maury et al., 2007). Mice lacking PAM do not survive past E13.5; thin arterial walls and edema are apparent at E12.5 (Czyzyk et al., 2005). Mice with a single copy of the PAM gene are viable (Czyzyk et al., 2005, Bousquet-Moore et al., 2009). Along with mild glucose intolerance, PAM+/− mice showed deficits in peripheral vasoconstriction; supplemental copper reversed this deficit (Bousquet-Moore et al., 2009). By coupling our analysis of functional impairments in PAM heterozygous mice (PAM+/−) to dietary manipulations of copper, we sought to identify indicators of peptidergic dysfunction and mild copper deficiency.

We exposed PAM+/− mice and their wildtype (WT) littermates to either a copper-deficient or copper-supplemented diet. Dietary copper deficiency in WT mice increased anxiety-like behavior and seizure sensitivity, deficits similar to those observed in PAM+/− mice. Supplementary copper ameliorated some, but not all, of the deficits observed in PAM+/− mice. In addition, we found that copper status differed in PAM+/− and WT mice on the control diet. This unexpected finding led to the hypothesis that PAM is linked to the ability of an organism to provide copper to tissues. Comparisons of gene expression profiles in PAM+/− vs. WT mice confirmed this hypothesis.

Section snippets

Animal care and use

Male and female PAM+/− and C57BL/6J WT littermates (2–5 months old) were used in these experiments; male PAM+/− mice were bred with female C57BL/6J WT mice from Jackson Labs (Bar Harbor ME). All had been backcrossed more than 12 generations. Tail clips and/or ear tags taken at the time of weaning were used to determine the genotype (Bousquet-Moore et al., 2009). All protocols were approved by the Animal Care and Use Committee at the University of Connecticut Health Center.

Manipulation of dietary copper

WT and PAM+/− mice

Copper status in WT mice on copper-deficient and supplemented diets

Because our previous work demonstrated that copper supplementation restored the ability of PAM+/− mice to maintain body temperature in the cold (Bousquet-Moore et al., 2009), we wanted to assess the effects of marginal copper deficiency on WT mice. Copper deficiency was created by feeding adult male mice a diet containing 0.6 ppm Cu/kg instead of 15 ppm Cu/kg for 9 weeks. Copper status was assessed by measuring total liver copper (Fig. 1A), serum ceruloplasmin (Fig. 1B) and liver levels of

Effects of PAM heterozygosity are widespread and diverse

In organisms as simple as Planaria and Hydra, amidated peptides play multiple roles in normal physiology (Asada et al., 2005). Since PAM is the only enzyme known to synthesize amidated peptides, we used mice with a single functional copy of PAM to identify functions that were most sensitive to a decrease in PAM and dietary copper. While haploinsufficiency of many genes is without effect, a single functional copy of the vesicular monoamine transporter 2 gene (Fukui et al., 2007) or various ion

References (81)

  • KumarN.

    Copper deficiency myelopathy (human swayback)

    Mayo Clin. Proc.

    (2006)
  • KuoY.M. et al.

    Copper transport protein 1 (Ctr1) levels in mice are tissue specific and dependent on copper status

    J. Nutr.

    (2006)
  • MaX.M. et al.

    Plasticity in hippocampal peptidergic systems induced by repeated electroconvulsive shock

    Neuropsychopharmacology

    (2002)
  • MauryA. et al.

    Neonatal onset of Menkes disease: diagnosis interest of cupremia and microscopic examination of the hairs

    Arch. Pediatr.

    (2007)
  • MendelsohnB.A. et al.

    ATP7a determines a hierarchy of copper metabolism essential for notochord development

    Cell Metab.

    (2006)
  • MerchantS.S. et al.

    Precious metal economy

    Cell Metab.

    (2006)
  • MerklerD.J.

    C-terminal amidated peptides: production by the in vitro enzymatic amdiation of glycine-extended peptides and the importance of the amide to biological activity

    Ezyme. Microb. Technol.

    (1994)
  • MullerP.A. et al.

    Atox1: a novel copper-responsive transcription factor in mammals?

    Int. J. Biochem. Cell Biol.

    (2009)
  • NiciuM.J. et al.

    Developmental changes in the expression of ATP7a during a critical period in postnatal neurodevelopment

    Neuroscience

    (2006)
  • NiciuM.J. et al.

    Altered ATP7a expression and other compensatory responses in a murine model of Menkes disease

    Neurobiol. Dis.

    (2007)
  • NillniE.A. et al.

    Deficiencies in pro-thyroptropin-releasing hormone processing and abnormalities in thermoregulation in CPEfat/fat mice

    J. Biol. Chem.

    (2002)
  • NishikimiM. et al.

    Cloning and chromosomal mapping of the human nonfunctional gene for L-gulono-gamma-lactone oxidase, the enzyme for L-ascorbic acid biosynthesis missing in man

    J. Biol. Chem.

    (1994)
  • NittisT. et al.

    Role of copper in the proteosome-mediated degradation of the multicopper oxidase hephaestin

    J. Biol. Chem.

    (2004)
  • PenlandJ.G. et al.

    Abnormal motor function persists following recovery from perinatal copper deficiency in rats

    J. Nutr.

    (2004)
  • ProhaskaJ.R. et al.

    Plasma peptidylglycine alpha-amidating monooxygenase (PAM) and ceruloplasmin are affected by age and copper status in rats and mice

    Comp. Biochem. Physiol. B Biochem. Mol. Biol.

    (2006)
  • ProhaskaJ.R. et al.

    Intracellular copper transport in mammals

    J. Nutr.

    (2004)
  • ProhaskaJ.R. et al.

    Metallochaperone for Cu,Zn-superoxide dismutase (CCS) protein, but not mRNA is higher in organs from copper deficient mice and rats

    Arch. Biochem. Biophys.

    (2003)
  • ProhaskaJ.R. et al.

    Peptidylglycine-alpha-amidating monooxygenase activity and protein are lower in copper-deficient rats and suckling copper-deficient mice

    Arch. Biochem. Biophys.

    (2005)
  • PuigS. et al.

    Molecular mechanisms of copper uptake and distribution

    Curr. Opin. Chem. Biol.

    (2002)
  • RajagopalC. et al.

    Multiple phosphorylation, cleavage, and nuclear translocation of the unstructured PAM cytosolic domain

    J. Biol. Chem.

    (2009)
  • TirassaP. et al.

    CCK-8 prevents the development of kindling and regulates the GABA and NPY expression in the hippocampus

    Neuropharmacology

    (2005)
  • WoldbyeD.P. et al.

    Neuropeptide Y inhibits hippocampal seizures and wet dog shakes

    Brain Res.

    (1996)
  • WoldbyeD.P. et al.

    Differential suppression of seizures via Y2 and Y5 receptors

    Neurobiol. Dis.

    (2005)
  • Al-BitarY. et al.

    Menke's kinky hair syndrome-a rare medical condition

    J. Pak. Med. Assoc.

    (2005)
  • AndreiniC. et al.

    Occurence of copper proteins through the three domains of life: a bioinformatic approach

    J. Proteome Res.

    (2008)
  • AsadaA. et al.

    Planarian peptidylglycine-hydroxylating monooxygenase, a neuropeptide processing enzyme, colocalizes with cytochrome b561 along the central nervous system

    FEBS J.

    (2005)
  • BarabanS.C. et al.

    Knockout mice reveal a critical antiepileptic role for neuropeptide Y

    J. Neurosci.

    (1997)
  • BellJ. et al.

    Mechanistic investigation of peptidylglycine alpha-hydroxylating monooxygenase via intrinsic tryptophan fluorescence and mutagenesis

    Biochemistry

    (2003)
  • BhatR.V. et al.

    Rapid increases in peptide processing enzyme expression in hippocamal neurons

    J. Neurochem.

    (1993)
  • Bousquet-MooreD. et al.

    Reversal of physiological deficits caused by diminished levels of peptidylglycine alpha-amidating monooxygenase by dietary copper

    Endocrinology

    (2009)
  • Cited by (44)

    • Posttranslational Modifications: Key Players in Health and Disease

      2022, Encyclopedia of Cell Biology: Volume 1-6, Second Edition
    • Posttranslational Modifications: Key Players in Health and Disease

      2022, Encyclopedia of Cell Biology: Volume 1-6, Second Edition
    • Amino acids: Peptidylglycine a-Amidating Monooxygenase (PAM)

      2021, Encyclopedia of Biological Chemistry: Third Edition
    • Serum, erythrocyte and urinary concentrations of iron, copper, selenium and zinc do not change during an incremental test to exhaustion in either normothermic or hyperthermic conditions

      2019, Journal of Thermal Biology
      Citation Excerpt :

      Therefore, Cu participates in haemoglobin synthesis (Myint et al., 2018), an essential protein for aerobic endurance. In hot environments, Cu takes part in thermal regulation and glucose metabolism (Bousquet-Moore et al., 2010). Cu deficiency can impair the immune and cardiovascular systems.

    • Report of a novel ATP7A mutation causing distal motor neuropathy

      2019, Neuromuscular Disorders
      Citation Excerpt :

      Copper deficiency is the main pathogenic mechanism for MD and OHS and the early institution of copper-replacement therapy affects prognosis for MD patients [19]. Animal models have shown that in the peripheral and central nervous systems, copper is essential for the normal functions of cuproenzymes such as ceruloplasmin, hephaestin, copper-zinc superoxide dismutase (SOD1), cytochrome c oxidase (CCO), dopamine-β-hydroxylase (DβH), peptidyl α-amidating monooxygenase (PAM) and tyrosinase [20,21] and that axonal ATP7A expression during synaptogenesis is essential for normal neuronal development. Further underlining the relevance of copper metabolism in Charcot-Marie-Tooth disease, very recently compound heterozygous variants in the mitochondrial copper-binding protein SCO2, were identified in two unrelated patients with axonal polyneuropathy [22].

    View all citing articles on Scopus
    View full text